Tune in to POLITICO’s Healthcare Summit

POLITICIAN Health Care Summit it’s happening now and you still have time to tune in for the biggest days journalists:

Representative. Greg Murphy (RN.C.) on the health care spending crisis

Representative. Debbie Dingell (D-Mich.) on financially viable care

White House Covid-19 Response Coordinator Ashish Jha on overcoming the health emergency

Secretary of Health and Human Services Saverio Becerra on the record and priorities of the Biden administration

POLITICIAN by David Lim detail the critical issues the White House, Congress and regulators must address and that our reporters will ask:

Ensure solvency health care programs for retirees and at-risk families, even though many Democrats want health care to be free for all;

Making sure the the current regulatory framework is tasked with reviewing and approving increasingly complex cell and gene therapy products developed by the pharmaceutical industry;

Restore lost trust in government when it comes to messaging and handling public health emergencies.

Capture everything POLITICO.com livestream.

This is where we explore the ideas and innovators shaping healthcare.

Share thoughts, news, tips and feedback with Ben Leonard on [email protected]Ruth Reader a [email protected]Carmen Paun a [email protected] or Erin Schumaker a [email protected].

Submit tips securely via SecureDrop, Signal, Telegram or WhatsApp.

Today on ours Pulse check podcasts, join us for a discussion at today’s POLITICO Health Care Summit, where we will explore the transformative impact of technology and innovation on health care and the challenges facing the United States as the country grapples with improving health access to quality care for all Americans. Megan Messerly chats with David Lim, who tells us what to expect.

Legislation for updating PEPFARthe anti-AIDS program created by former President George W. Bush is in doubt after a key Republican said it must include anti-abortion language.

The President’s Emergency AIDS Relief Plan has long enjoyed bipartisan support and is widely credited with stemming the spread of HIV and AIDS. It is awaiting a new congressional authorization this year.

But a letter to colleagues in the Rep. Chris Smith (RN.J.), the chair of the Foreign Affairs Subcommittee on Global Health, Global Human Rights, and International Organizations, risks creating a partisan rift.

Any multi-year PEPFAR reauthorization legislation must ensure that Biden’s hijacking of PEPFAR to promote abortion is stopped, Smith wrote. in the letter that Carmen got.

Smith referred to Biden administration policy documents that he says seek to use PEPFAR to fund organizations that support abortion rights or provide abortions, as well as more than $100 million in funding that has gone to groups like Population Services International, Village Reach and Pathfinder International since Joe Biden became president.

Anti-abortion groups wrote to Rep. Michael McCaul (R-Texas), the chairman of the Foreign Affairs Committee, and Sen. Jim Risk (R-Idaho), the ranking member of the Foreign Relations Committee, raise concerns on PEPFAR grants last month.

Because matter: Sponsored Smith the latest reauthorization law in 2018 and the bill would normally go through its subcommittee.

Congress can keep PEPFAR as-is without passing new legislation, but the reauthorization process is an opportunity to make policy changes or update authorized funding levels.

What’s next? Smith’s position could dim Democrats’ enthusiasm for reauthorizing PEPFAR this year.

That will disappoint HIV/AIDS activists and public health officials who say a bipartisan reauthorization of the program would signal a renewed U.S. commitment to fighting the disease, which has spread more widely during the Covid-19 pandemic.

Get more doctors to offer telehealth faces a significant obstacle: many of them do not trust virtual assistance.

According to a new study of 2,000 physicians worldwide by health technology company GE Healthcare, just over half of physicians believe they can accurately diagnose patients using telehealth and remote patient monitoring.

Overall, two-thirds of providers are unsure whether patients can perform the necessary tests at home unsupervised in a way that will reassure their doctors.

Cultural split: This sentiment varied significantly across the eight countries GE Healthcare surveyed.

Along with the UK, the US had the second-highest level of distrust of unsupervised extraclinical testing at 79%, lower only than South Korea at 82%.

Germany had the lowest level of distrust of such tests at 48%, followed by Brazil at 55%, India at 60%, China at 62% and New Zealand at 63%.

The difference may lie in telehealth adoption rates, the company said. In Germany, which has had relatively high levels of trust in self-testing, nearly three-quarters of providers often see patients virtually.

On the other hand, in South Korea, where less than 1 in 5 providers frequently use telehealth, about the same shared confidence that patients can self-test without supervision.

#Tune #POLITICOs #Healthcare #Summit

Leave a Comment